chr18-65822007-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004361.5(CDH7):c.626-74C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.055 in 1,169,118 control chromosomes in the GnomAD database, including 3,357 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.094 ( 1221 hom., cov: 32)
Exomes 𝑓: 0.049 ( 2136 hom. )
Consequence
CDH7
NM_004361.5 intron
NM_004361.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.101
Genes affected
CDH7 (HGNC:1766): (cadherin 7) This gene encodes a type II classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium dependent cell-cell adhesion molecule is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Type II (atypical) cadherins are defined based on their lack of a histidine-alanine-valine (HAV) cell adhesion recognition sequence specific to type I cadherins. Cadherins mediate cell-cell binding in a homophilic manner, contributing to the sorting of heterogeneous cell types. Mutations in this gene may be associated with bipolar disease in human patients. This gene is present in a gene cluster on chromosome 18. [provided by RefSeq, May 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 18-65822007-C-T is Benign according to our data. Variant chr18-65822007-C-T is described in ClinVar as [Benign]. Clinvar id is 1248353.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.219 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDH7 | NM_004361.5 | c.626-74C>T | intron_variant | ENST00000397968.4 | |||
CDH7 | NM_001317214.3 | c.626-74C>T | intron_variant | ||||
CDH7 | NM_001362438.2 | c.626-74C>T | intron_variant | ||||
CDH7 | NM_033646.4 | c.626-74C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDH7 | ENST00000397968.4 | c.626-74C>T | intron_variant | 1 | NM_004361.5 | P1 | |||
CDH7 | ENST00000323011.7 | c.626-74C>T | intron_variant | 1 | P1 | ||||
CDH7 | ENST00000536984.6 | c.626-74C>T | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.0943 AC: 14343AN: 152024Hom.: 1218 Cov.: 32
GnomAD3 genomes
AF:
AC:
14343
AN:
152024
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0491 AC: 49917AN: 1016976Hom.: 2136 AF XY: 0.0509 AC XY: 26671AN XY: 523880
GnomAD4 exome
AF:
AC:
49917
AN:
1016976
Hom.:
AF XY:
AC XY:
26671
AN XY:
523880
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0944 AC: 14355AN: 152142Hom.: 1221 Cov.: 32 AF XY: 0.0928 AC XY: 6907AN XY: 74392
GnomAD4 genome
AF:
AC:
14355
AN:
152142
Hom.:
Cov.:
32
AF XY:
AC XY:
6907
AN XY:
74392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
366
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 18, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at